Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @RiverVest
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RiverVest
-
San Diego’s Life Science Venture Capital Scene, a view from our Managing Director
@NancyAHong#VC#Startups#biotech#lifechanging https://sandiegolifechanging.org/blog/san-diegos-life-science-venture-capital-scene/ …pic.twitter.com/PyvcYUGTcj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest proslijedio/la je Tweet
Excited to announce our $25 million Series D raise, preparing us for commercial launch in June.
#biotech#drugdiscovery#research#multiplex#inflammation#oncology#cardiovascular#biomarkershttps://twitter.com/dnickbiz/status/1224783966005317634 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Beautiful story about our Managing Director Derek Rapp and his family’s enormous commitment to
@JDRF : Where Are They Now? Derek and Emily Rapp Seek to Grow Support for JDRFhttps://www.jdrf.org/blog/2020/01/31/where-are-they-now-derek-and-emily-rapp-seek-to-grow-support-for-jdrf/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest proslijedio/la je Tweet
We are hiring! Career opportunities in
#research#marketing#sales in St. Louis.#stlmadehttps://adarzabio.com/contact-us/careers-2/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest proslijedio/la je Tweet
Is your
#bioscience#startup fundraising? As the team wraps up at#JPM2020 one of our entrepreneurs in residence and a bioscience#VC,@KarenSpilizewsk of@RiverVest, shares her top 5 takeaways for#entrepreneurs hoping to raise capital: http://bit.ly/2RmIrLk pic.twitter.com/7p4DOWV48l
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to RiverVest Managing Director
@NancyAHong for being named one of the most influential business leaders in San Diego!#VC#biopharma#biotech#leadership#lifescienceshttp://sdbj.com/news/2018/jan/05/sd-500-nancy-hong/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congratulations to Ciara Kennedy, CEO of RiverVest portfolio company Amplyx, for being named one of the most influential business leaders in San Diego! http://sdbj.com/news/2018/jan/09/sd-500-ciara-kennedy/ …
#biotech#leadership#therapies#immunocompromisedHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest co-founder Tom Melzer shares insights on
#STL venture capital and startup growth for 2020 in today's@stlouisbiz http://bizj.us/1q15iy#biopharma#STLMade@BRDGPark@CortexSTL@DowntownTREX#endcancer#immunotherapy#genetherapy#VCpic.twitter.com/TsTC8stjTb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest portfolio company
@mirumpharma completed a successful pre-new drug application meeting with the FDA for Maralixibat, a drug to treat pruritus associated with Alagille syndrome. https://www.rivervest.com/mirum-pharmaceuticals-completes-successful-pre-nda-meeting-with-fda-for-maralixibat/ …#biopharma#liverdiseaseHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to the Medtech Partnering Conference 2020 where Jay Schmelter, RiverVest managing director, is scheduled to speak. https://tdg.ucla.edu/medtech-partnering-conference-2020 …
@UCLATDG#medtech#bioscience#UCLA#innovation#HealthHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest portoflio co. Wugen targets 2020 for Series A funding, start of clinical trials. RiverVest managing director John McKearn is president & CEO. http://ow.ly/k2Jp50xdMgq
#CarT#Tcell#immunotherapy#oncologyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
FDA granted 'Breakthrough Therapy Designation' to Maralixibat, RiverVest portfolio co.
@mirumpharma's oral drug to treat pruritus from#AlagilleSyndrome. Designation was based on Phase 2b clinical trial shared at Internat'l Liver Congress.http://ow.ly/PXRv50wVC3lHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to our portfolio co. InterVene Medical for winning 1st place (and $200k) at the
#TCT2019 Shark Tank out of 50 global clinical stage companies in cardiac, vascular and neuro!pic.twitter.com/o1OFK2UKxQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest portfolio company Spruce Biosciences, a clinical stage biotech co., announced positive 2a study results from Spruce's oral, non-steroid treatment of CAH, a rare genetic disorder affecting the ability of the adrenal glands to function properly.http://ow.ly/XFzv50wiaOv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Gene therapy is back in business thanks to pioneer James Wilson, and we’re thrilled to have co-led the $20 million Series B round for his
@scoutbio RiverVest’s@NancyAHong serves on the ScoutBio board.https://cen.acs.org/business/The-redemption-of-James-Wilson-gene-therapy-pioneer/97/i36 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest proslijedio/la je Tweet
Huge win for the region and for our region’s long-term civic focus to invest and grow our
#biotech#agtech strength.@DanforthCenter@BioSTL@BioGeneratorSTL@MoTechCorp@RiverVesthttps://twitter.com/ChrisNagusKMOV/status/1161391523067510784 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest proslijedio/la je Tweet
As its assets ascend toward $1B, St. Louis VC firm expands again https://www.bizjournals.com/stlouis/news/2019/07/23/as-its-assets-ascend-toward-1b-st-louis-vc-firm.html … via
@stlouisbizHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest continues team expansion with new managing director, Derek Rapp, and senior associate, Isaac Zike, PhD. http://ow.ly/fyzh50v9dyw
#VC#lifesciences#drugdiscovery#entrepreneurs#unmetneeds#innovation#STLmadeHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
RiverVest portfolio company Mirum Pharmaceuticals announces pricing of IPO. http://ow.ly/t0DI50v4U0r
#liverdiseaseHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
WUGEN, a RiverVest Venture Partners seed investment, is targeting T-cell cancers using CAR-T Therapy. http://ow.ly/jsZh50v4TMW
#cancer#VC#lifescience#cancertherapyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.